Riccardo Pigliucci Executive Chairman (Acting)	Riccardo Pigliucci has been working with Capsant on its commercialisation strategy since November 2007.  Mr. Pigliucci has served as managing partner of Aldwych Associates LLP, a management and technology consulting partnership.  From May 1999 to November 2005, Mr. Pigliucci served as Chairman and Chief Executive Officer of Discovery Partners International, a drug discovery services company.  From February 1996 to April 1998, he served as Chief Executive Officer of Life Sciences International PLC, a global supplier of scientific equipment and consumables.  Prior to that, Mr. Pigliucci served in a number of capacities at The Perkin Elmer Corporation, now Applera Corporation, a global life sciences company, most recently as President and Chief Operating Officer.  Mr. Pigliucci currently serves as a director of the Dionex Corporation, Biosphere Medical and several privately held technology companies.
Lars Sundstrom Chief Scientific Officer	Lars Sundstrom is Chief Scientific Officer and a founder of Capsant Neurotechnologies Ltd. Pr. Sundstrom has a degree in biochemistry and a PhD from Oxford University and has held research positions at the University of Geneva and Bordeaux. Before forming Capsant, Prof. Sundstrom was Director and Head of Clinical Neurosciences at Southampton University.
Luc Stoppini Research Director	Luc Stoppini is R&D director for Capsant Neurotechnologies and has held academic positions at the Universities of Lyon, Geneva and Virginia. Dr Stoppini has been involved in commercialising technology for the last 10 years, and pioneered the development of organotypic slice cultures on an air liquid interface.Prior to joining Capsant Luc was developing in-vitro models of multiple sclerosis with Serono in Geneva.
Dan Komarek Director of Business Development	Dan Komarek has twenty years of business, technical and operational experience with start-up biotech, government and large life science companies.  Prior to working with Capsant. Mr. Komarek worked at BD Biosciences as the Director of Business Development where he focused on product development of instrumentation and software for the high content screening market.  Prior to joining BD he was the Director of the Gene Discovery Services program at Invitrogen/Life Technologies where he oversaw the development and management of a new contract service program. Mr. Komarek has also held positions at Bioreliance as the Lab Director where he helped establish and manage a new GMP bioanalytical group and with Oncologix a start-up cancer biotech company.